Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 11

Results For "IMA"

2853 News Found

Nirsevimab EMA regulatory submission accepted under accelerated assessment
Biotech | February 17, 2022

Nirsevimab EMA regulatory submission accepted under accelerated assessment

Nirsevimab is the first investigational long-acting antibody designed to protect all infants for the respiratory syncytial virus season with a single dose


Lilly's bebtelovimab receives EUA to treat mild-to-moderate Covid-19
Drug Approval | February 14, 2022

Lilly's bebtelovimab receives EUA to treat mild-to-moderate Covid-19

Bebtelovimab neutralizes Omicron as demonstrated by pseudo virus and authentic virus data


NMPB and CSIR-CIMAP sign MoU for joint collaboration
Policy | December 08, 2021

NMPB and CSIR-CIMAP sign MoU for joint collaboration

Working under the Ministry of Ayush, NMPB is mandated to coordinate all matters relating to medicinal plants and support policies and programs for growth of trade, export, conservation, and cultivation of medicinal plants


Fujifilm collaborates with DCC Animal hospital for diagnostics support
Diagnostic Center | December 07, 2021

Fujifilm collaborates with DCC Animal hospital for diagnostics support

Fujifilm India will be providing healthcare Imaging devices and equipment’s to increase the standards of the veterinary care in India.


Lilly's bamlanivimab with etesevimab authorized for emergency use in Covid-19 patients under 12
Drug Approval | December 06, 2021

Lilly's bamlanivimab with etesevimab authorized for emergency use in Covid-19 patients under 12

Expanded EUA includes both treatment of patients with Covid-19 and post-exposure prophylaxis (PEP) in high-risk pediatric and infant patients


GSK's antibody drug sotrovimab works against Omicron mutations
Biotech | December 02, 2021

GSK's antibody drug sotrovimab works against Omicron mutations

Preclinical data demonstrate sotrovimab, authorised in multiple countries around the world, retains activity against all tested variants of concern, including key mutations of Omicron


Asian Development Bank to loan US $ 300 mn to improve India’s primary healthcare
Public Health | November 24, 2021

Asian Development Bank to loan US $ 300 mn to improve India’s primary healthcare

The programme will be implemented across 13 states and benefit 256 min


US govt signs deal with GSK and Vir Biotechnology to buy sotrovimab, a Covid-19 treatment
Biotech | November 18, 2021

US govt signs deal with GSK and Vir Biotechnology to buy sotrovimab, a Covid-19 treatment

The final data from the trial showed sotrovimab reduces hospitalisation and risk of death by 79% in adults with mild-to-moderate Covid-19 who are at high risk of progression to severe disease


Tripura CM inaugurates advanced imaging facility at Niramay Health centre
Medical Device | November 15, 2021

Tripura CM inaugurates advanced imaging facility at Niramay Health centre

Carestream equipment is highly recommended for its imaging quality


Boehringer Ingelheim announces EMA marketing authorisation for spesolimab
Drug Approval | October 29, 2021

Boehringer Ingelheim announces EMA marketing authorisation for spesolimab

Generalized pustular psoriasis is characterized by episodes of widespread eruptions of painful, sterile pustules